§ 868.1120. Indwelling blood oxyhemoglobin concentration analyzer.
173 words·~1 min read·
/us/cfr/t21/s§ 868.1120·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. An indwelling blood oxyhemoglobin concentration analyzer is a photoelectric device used to measure, in vivo, the oxygen-carrying capacity of hemoglobin in blood to aid in determining the patient's physiological status.
(b)Classification. Class III (premarket approval).
(c)Date PMA or notice of completion of PDP is required. A PMA or notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before September 21, 2004, for any indwelling blood oxyhemoglobin concentration analyzer that was in commercial distribution before May 28, 1976, or that has, on or before September 21, 2004, been found to be substantially equivalent to an indwelling blood oxyhemoglobin concentration analyzer that was in commercial distribution before May 28, 1976. Any other indwelling blood oxyhemoglobin concentration analyzer shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution. [47 FR 31142, July 16, 1982, as amended at 52 FR 17735, May 11, 1987; 52 FR 22577, June 12, 1987; 69 FR 34920, June 23, 2004]
Connections2 cite this
Citation graph
cites case law
§ 868.1120
Indwelling blood oxyhemoglobin concentration analyzer.
Fed. Reg.×2
Cites 0Cited by 2 across 1 source